I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| natural killer cell | 13 studies | 20% ± 4% | |
| CD16-positive, CD56-dim natural killer cell, human | 10 studies | 21% ± 4% | |
| CD16-negative, CD56-bright natural killer cell, human | 7 studies | 20% ± 4% | |
| epithelial cell | 4 studies | 20% ± 3% | |
| lymphocyte | 4 studies | 20% ± 4% | |
| glutamatergic neuron | 4 studies | 29% ± 9% | |
| CD8-positive, alpha-beta T cell | 3 studies | 20% ± 3% | |
| plasma cell | 3 studies | 22% ± 8% | |
| GABAergic neuron | 3 studies | 30% ± 1% | |
| transit amplifying cell | 3 studies | 22% ± 5% | |
| astrocyte | 3 studies | 20% ± 3% |
